In my last blog we began discussing the MDS-measured metrics, specifically the Percentage of short-stay residents who made improvements in function. Let’s continue discussing how your pharmacy can contribute to improvement in this key metric.

GrandView Pharmacy has the ability to take medication management one step further, by utilizing pharmacogenomics testing. From a simple cheek swab, we can determine which medications are best metabolized by the resident’s unique body chemistry. That’s right; what works for one person may not work for someone else with an identical disease. By obtaining these results (which can be done within a week), we can eliminate the costly, time consuming, and potentially harmful trial and error process. This testing can even help determine the best pain management medications for the particular resident, providing them effective relief, without intoxication and the need for increased side effects due to higher doses needed of inappropriate therapy to experience “pain relief”.

Our pharmacy also works with facilities to manage another all too common disease-COPD. It’s been estimated that around 6% of U.S. adults have COPD and according to the National Heart, Lung, and Blood Institute, it is the third most common cause of death in the U.S. Because it is an illness that takes years to develop, it is most commonly seen in the adult and elderly population. COPD is a complex disease that is often associated with multiple comorbidities, and has a wide scope of treatments. GrandView Pharmacy works with facilities to help them implement the GOLD (Global Initiative for Chronic Obstructive Lung Disease) strategy to aid in the diagnosis, management, and prevention of COPD. The GOLD program was founded in 1998 and since then, has worked diligently to determine best practices when it comes to preventing and treating COPD. It is our goal to give our facilities the knowledge and tools to put these practices into place for their residents.

We can’t discuss ADL improvement without touching on the role of medical equipment. Just one of the things that sets GrandView apart from other pharmacies, is that we house our own medical equipment division, offering medical equipment for purchase and rental to facilities, as well as working directly with residents discharging to home. Our equipment rental program helps ensure your residents are working with the correct equipment, specific to their needs, without requiring a large capital investment from the facility. Not only does this allow the resident to achieve the highest possible outcomes with ADL improvement, it expands the breadth of complexity and acuity of residents the facility is able to admit.

I hope you found my analysis helpful on how your pharmacy can contribute, in meaningful and often overlooked ways, to improvement in this key metric. GrandView has worked diligently to develop offerings that bleed outside of the lines of a traditional institutional pharmacy because we understand how valuable a true business partner can be to a community. Next up, we’ll be tackling Percent of long stay residents whose ability to move independently worsened, another MDS-based metric.